Bayer plans USD 2.20 billion Ohio site. Bayer stock falls 1.09 percent

Published on 10/05/2026 at 14:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached EUR 10.87 billion, up 2.20 percent year over year. Bayer stock costs EUR 44.59 on October 5, 2026 versus EUR 45.08.

Extremmakroaufnahme einer weißen Tablette, in zwei Hälften gebrochen; die körnig-kristalline Bruchfläche ist scharf, dunkler Untergrund, dramatisches Seitenlicht von links — Extremmakro einer gebrochenen weißen Tablette: kristalline Bruchstruktur vor dunkelgrauem Hintergrund, Illustration mit AI erstellt.

Bayer (ISIN DE000BAY0017) plans a USD 2.20 billion pharmaceutical manufacturing site in Ohio, while Bayer stock was trading at EUR 44.59 at Lang & Schwarz on October 5, 2026, down 1.09 percent from the prior close of EUR 45.08. Bayer said on October 2, 2026, that the planned site in New Albany, Ohio, will serve patients in the United States and worldwide and create 600 jobs.

Ohio investment targets pharmaceuticals

The investment expands Bayer's manufacturing footprint in the United States and adds a concrete capital commitment to the company's pharmaceutical strategy. The project is designed as a multi-year investment, making execution and the timing of production capacity important factors for the shares.

The announcement follows Bayer's second-quarter 2026 operating update. According to Bayer, group sales increased 2.20 percent year over year to EUR 10.87 billion in the second quarter of 2026, while EBITDA before special items rose 1.90 percent to EUR 2.14 billion. Adjusted earnings per share increased 16.70 percent in the same period.

Analyst target stays above the price

JPMorgan kept its Overweight rating and a EUR 61.00 price target on Bayer in its October 1, 2026 note. finanzen.net reported that analyst Richard Vosser viewed early expectations for the third quarter as high, while treating the pressure in Crop Science as timing-related.

Bayer's next scheduled results date is November 3, 2026. finanzen.ch reported that the second-quarter figures included earnings per share of EUR 0.23, compared with a loss of EUR 0.20 per share in the year-earlier quarter.

Bayer stock remains below its yearly high

The Lang & Schwarz price of EUR 44.59 stood below Bayer's 52-week high of EUR 53.92 and above its 52-week low of EUR 25.78 on October 5, 2026. The finance data quote put Bayer's market capitalization at EUR 43.8 billion on the same date, giving the Ohio project a material scale relative to the listed company's equity value.

Bayer stock was trading at EUR 44.59 at Lang & Schwarz on October 5, 2026 at 2:19 p.m. CEST, down 1.09 percent versus the Lang & Schwarz prior close of EUR 45.08 on October 2, 2026. The further course of trading is shown by the continuously updated real-time quote of Bayer stock.